Improving patients’ health is our mission

cri

About Clinical Research Institute

Да бъдем водеща изследователска организация в България, която работи за подобряване качеството на живот на пациентите; да се стремим да развиваме различна по вид изследователска дейност като залагаме на иновативния и гъвкав подход; да сътрудничим успешно с нашите клиенти и партньори и да допринасяме за удовлетвореността в работата на нашите служители.

Vth International Meeting on New Aspects in the Treatment of Breast Cancer and Prostate Cancer, Young Oncologist Club Bulgaria

By |December 18th, 2014|Events|

Herceptin for HER2-positive breast cancer improves long-term survival

The study, published in the Journal of Clinical Oncology, analyzed data from two independent trials designed to examine overall survival of patients with early-stage HER2-positive breast cancer who receivedchemotherapy with and without Herceptin.

The authors note that over 4,000 patients with HER2-positive operable breast cancer were enrolled and given “doxorubicin and cyclophosphamide followed by paclitaxel with […]

By |December 16th, 2014|General|

Breast cancer vaccine shows promise in small clinical trial

By Julia Evangelou StraitA breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.The study […]

By |December 1st, 2014|General|

FDA approves new melanoma drug that turns on the immune system to fight deadly cancers

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

The drug, Keytruda, was tested on more than 600 patients who had melanoma that had spread throughout their bodies. Because so many of the patients in the […]

By |September 4th, 2014|General|